Hot-Jing Biology's (688068.SH) subsidiary SGC001 injection liquid has been approved for clinical trial application for new indications.

Zh tng cijng APP xn, r jng shngw (688068.SH) fb gnggo, jnr, gngs kngg zgngs bijng shn jng shngw yyo jsh yuxin gngs (jinchng shn jng yyo) zzh ynf de chungxn yo SGC001 zhjngy xn zng yq zhng xng j pnrn yn yn sh lnchung shyn shnqng hud guji yopn jindgunlj xif de shu l tngzhsh.